Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeremy P. Springhorn currently holds 15,840 shares of Syros Pharmaceuticals, Inc. (SYRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeremy P. Springhorn has been a net buyer of SYRS stock. They have purchased $235.8K and sold $179.5K worth of shares.
Jeremy P. Springhorn's most recent insider trade was on Jun 19, 2024, when they sold 15,840 shares at $0.00 per share.
Jeremy P. Springhorn serves as Executive at Syros Pharmaceuticals, Inc. (SYRS). They have executed 21 insider transactions totaling $415.3K over their tenure at the company.
Jeremy P. Springhorn holds the position of Executive at Syros Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Jeremy P. Springhorn has shown a buying trading pattern, with $235.8K in total purchases and $179.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jeremy P. Springhorn was on Dec 15, 2017, when they purchased $136.2K worth of SYRS shares. This transaction involved 15,000 shares at $9.08 per share.
Jeremy P. Springhorn currently owns 15,840 shares of Syros Pharmaceuticals, Inc. (SYRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeremy P. Springhorn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeremy P. Springhorn has 21 Form 4 filings on record as an insider at Syros Pharmaceuticals, Inc..
Set alerts for Jeremy P. Springhorn and 40,000+ other insiders.